Rationale for Effective Prophylaxis Against COVID‐19 Through Simultaneous Blockade of Both Endosomal and Non‐Endosomal SARS‐CoV‐2 Entry into Host Cell

Documenti analoghi

• Lessons from SARS and MERS remind us of the possible therapeutic effects of implementing a siRNA strategy to target COVID‐19: Shoot the messenger!
  di: Habtemariam, Solomon, et al.
  Pubblicazione: (2020)
• Possible use of the mucolytic drug, bromhexine hydrochloride, as a prophylactic agent against SARS-CoV-2 infection based on its action on the Transmembrane Serine Protease 2
  di: Habtemariam, Solomon, et al.
  Pubblicazione: (2020)
• Game of “crowning” season 8: RAS and reproductive hormones in COVID-19 – can we end this viral series?
  di: Cismaru, Andrei Cosmin, et al.
  Pubblicazione: (2020)
• Various interferon (IFN)-inducible transmembrane (IFITM) proteins for COVID-19, is there a role for the combination of mycophenolic acid and interferon?
  di: Dowran, Razieh, et al.
  Pubblicazione: (2020)
• Glucose-6-phosphate dehydrogenase deficiency and SARS-CoV-2 mortality: Is there a link and what should we do?
  di: Nabavi, Seyed Fazel, et al.
  Pubblicazione: (2020)